Anna Protopapas is a rarity in the corporate world. Not only is she one of a small number of top-ranking women in the biopharmaceutical industry, but as executive vice-president of global business development at Takeda Pharmaceuticals, she is also one of only a few women at the top of a Japanese company. (more…)
- Help
- •Contact us
- •About us
- •Sitemap
- •Advertise with the FT
- •Terms & Conditions
- •Privacy Policy
- •Copyright
© The Financial Times Ltd 2013 FT and 'Financial Times' are trademarks of The Financial Times Ltd.

